Low magnesium intake is associated with increased knee pain in subjects
with radiographic knee osteoarthritis: data from the Osteoarthritis Initiative.
低鎂攝入量與膝關節骨性關節炎患者膝關節疼痛增加有關:來自骨關節炎倡議的數據。
Lower magnesium intake was associated with worse pain and function in knee OA,
especially among individuals with low fiber intake.
較低的鎂攝入量與膝OA的疼痛和功能較差相關
Glucosamine, chondroitin, and manganese ascorbate for
degenerative joint disease of the knee or low back: a randomized,
double-blind, placebo-controlled pilot study.
葡萄糖胺,軟骨素和抗壞血酸錳用於膝關節或腰部退行性關節病:
一項隨機,雙盲,安慰劑對照試驗研究。
The combination therapy relieves symptoms of knee osteoarthritis.
聯合療法可緩解膝關節骨性關節炎的症狀。
鎂離子為透明質酸合成酶活性重要關鍵金屬離子
人體合成透明質酸需要鎂
透明質酸的製造需要有足夠的葡萄糖胺
葡萄糖胺以具有黏度的黏多醣存在於軟骨與結締組織的各處
錳參與黏多糖合成
小結1:
由以上可知,退化性關節炎缺鎂、錳。
IL4-10 synerkine,a fusion proten composed of IL-4 and IL-10
IL4-10 synerkine,一種由IL-4和IL-10組成的融合蛋白
Culturing OA cartilage in presence of IL4-10 synerkine increased
proteoglycan(PG) synthesis with 47.6%,+26.6% for IL-4 alone ,
+31.2% for IL-10 alone
在IL4-10 synerkine存在下培養OA軟骨增加蛋白多醣(PG)合成,
為47.6%,單獨IL-4為+ 26.6%,單獨IL-10為+ 31.2%
Interleukin-4, an inhibitor of cartilage breakdown
白細胞介素-4,軟骨破壞的抑製劑。
IL-4 significantly reduced the cartilage proteoglycan degradation
induced by IL-1 alpha, TNF-alpha, TNF-alpha plus IL-1 alpha
IL-4顯著降低IL-1α,TNF-α,TNF-α加IL-1α誘導的軟骨蛋白多醣降解
Blood-induced damage to the cartilage matrix was limited by IL-4
in a dose-dependent way (P < 0.05).
Also IL-10 limited this damage,
although to a lesser extent (P < 0.03).
血液誘導的軟骨基質損傷受IL-4的劑量依賴性限制(P <0.05)。
IL-10也限制了這種損傷,但程度較小(P <0.03)。
The effect of IL-4 plus
IL-10 was more pronounced and protective than IL-10 alone (P < 0.05).
IL-4加IL-10的作用比單獨的IL-10更顯著和保護作用(P <0.05)。
Recently, a direct anti-inflammatory, -catabolic and -apoptotic potential
of IL-10 in cartilage was described, suggesting a chondroprotective effect
of IL-10
最近,描述了IL-10在軟骨中的直接抗炎,抗分解代謝和抗凋亡潛力,提示IL-10的軟骨保護作用。
能提高IL-4的元素:鋅、維生素A
能提高IL-10的元素:鋅、錳、硒、維生素A、維生素D、維生素E
IGF-1也可促使軟骨細胞分化及增生
缺鎂3週後,IGF-1減少60%。
缺鋅17天後,IGF-1減少83%。
小結2:
由以上可知,退化性關節炎缺鎂、鋅、錳、維它命A、硒、維生素D